Rey Juan Carlos University
If you are the contact person for this centre and you wish to make any changes, please contact us.
Head of Urology Service, Hospital Universitario de Fuenlabrada, Madrid; Associate Professor of Health Sciences, Universidad Rey Juan Carlos; and Chairman of the Spanish branch of the European Randomized Study of Screening for Prostate Cancer
Former President of the Spanish Society of Arteriosclerosis (SEA), physician in the Internal Medicine Unit at the Fundación Alcorcón University Hospital, and tenured professor at Rey Juan Carlos University
PhD in Industrial Technologies, researcher in Metal-Organic Frameworks (MOF), Department of Chemical, Energy, and Mechanical Technology, Rey Juan Carlos University
PhD in Chemical Engineering, researcher in the high-performance research group in Chemical and Environmental Engineering at the Universidad Rey Juan Carlos.
Professor of Applied Economics at Rey Juan Carlos University
PhD in Biology, CSIC researcher and associate professor at the Universidad Rey Juan Carlos de Madrid
Professor of Biochemistry and Molecular Biology at the Universidad Rey Juan Carlos and coordinator of the LIPOBETA research group
Honorary Researcher with the Consolidated Research Group on Terrestrial Global Change and Environmental Geology at Rey Juan Carlos University
Lecturer in Audiovisual Communication and Advertising, coordinator of the Advertising and Public Relations strand of the Communication Sciences doctoral programme
Senior Lecturer in Social Psychology and Director of the Diversity Unit at Rey Juan Carlos University
Professor and coordinator of the Coastal and Marine Research Group (ZOCOMAR) of the Department of Biology and Geology, Physics and Inorganic Chemistry of the Rey Juan Carlos University
Professor of Pharmacology at the Rey Juan Carlos University
The HORIZON trial was the first to evaluate the potential effect on cardiovascular risk of a drug—pelacarsen—that reduces lipoprotein(a) levels in the blood. While this approach had generated high expectations, it did not prove successful in this trial, which involved 8,000 patients who had already experienced cardiovascular events. The negative results, which Novartis previewed in a press release in September, are being presented in full on November 7 at the American Heart Association congress and are published in NEJM.
Lipoprotein (a) is a particle that is very similar to, but distinct from, LDL, the ‘bad cholesterol’. Regarded as the hidden factor in cardiovascular risk, some scientific societies recommend that it be measured at least once in a person’s lifetime. The problem is that there are no treatments based on it to reduce the risk of heart attacks or strokes. This summer, the first clinical trial involving one of the drugs under investigation was completed and, contrary to expectations, the pharmaceutical company Novartis announced that the trial had failed: the reduction in lipoprotein (a) did not improve the participants’ health. The full results, which may call into question a long-accepted theory, will be presented on Saturday 7 November at the American Heart Association’s annual meeting.
Following a long night of negotiations and a two-week summit, the 17th Conference of the Parties to the Convention on Biological Diversity (COP17), held in Yerevan (Armenia), has concluded with minimal agreements. One of these is the ‘Yerevan Pathway’, which aims to accelerate the implementation of the Kunming-Montreal Global Biodiversity Framework adopted at COP15 and regarded as the equivalent of the Paris Agreement. The new agreement sets out the implementation of national plans, the mobilisation of financial resources and greater involvement from all sectors of society. COP17 also assessed progress towards the targets set, including protecting one-third of the land and oceans by 2030. According to The Climate Watch, the assessment reveals significant gaps between commitments and their implementation.
There are inequalities in the mental health of LGBTQIA+ people, supported by highly credible scientific evidence, particularly with regard to depression, suicidal behaviour and symptoms related to eating disorders. These are the main findings of a study led by IDIBAPS and published in the journal World Psychiatry, in which the researchers reviewed 22 systematic reviews with meta-analyses — comprising 398 studies on this topic — and analysed the 162 associations relating to mental health.
A study published in Scientific Reports estimates that the total area occupied by buildings within potentially flood-prone zones near the Himalayas increased by approximately 45 per cent between 2016 and 2023. In total, the study estimates that around 300,000 people could be at risk of flooding in the Nepalese, Indian and Chinese regions of the mountain range. Floods in the Himalayas are usually caused by monsoons, torrential rain or, on rare occasions, by devastating debris flows and glacial lake outbursts — such as the one that occurred last August. Climate change is expected to increase the severity of these events, whilst the narrow, steep valleys of mountainous areas can exacerbate the height of the floods and their consequences.
Women, particularly younger women, are disproportionately affected by painful conditions such as irritable bowel syndrome, endometriosis, menstrual migraines, fibromyalgia, osteoarthritis and neuropathic pain. A review published in Science summarises the latest advances in visceral and somatic pain, highlighting the impact of sex hormones, immunoneural interaction, the gut microbiota and endogenous analgesic circuits. These studies are beginning to explain why women experience more intense pain than men, paving the way for mechanism-based precision therapies. “Women are desperately hoping for concrete answers that can help dispel the common notion that ‘it’s all in your head’ when it comes to their conditions,” the authors note. The research forms part of a Science special issue on women’s health, which includes four further articles.
A combination of geological and climatic factors — the latter influenced by anthropogenic climate change — lay behind the catastrophic rock and ice avalanche last August on Nepal’s northern border, according to a review carried out by World Weather Attribution and glaciology experts. The team carried out an attribution analysis to examine the role of climate change in the rise in temperatures in July and August preceding the collapse, as well as in the region’s rainfall. According to the study, human-induced warming has raised the freezing line by around 100 metres per decade, leading to the thinning of glaciers and the thawing of the permafrost that held the mountain together. These factors, together with the destabilisation caused by a magnitude 7.8 earthquake in 2015, are believed to be the main causes of the landslide, which left more than a thousand people dead and thousands missing.
An international team has analyzed sea surface temperatures in the Atlantic Ocean and at various points in the Mediterranean Sea. The analysis, published by World Weather Attribution (WWA), shows that this year's temperatures have been extraordinary, both in their intensity and how early they have reached such magnitude. This behavior is not only having an ecological impact on marine life, the authors state, but could also exacerbate potentially destructive regional climate events like those that occurred in Valencia in 2024.
Various studies show that extreme heat is already influencing the decisions of international tourists, who are cutting short their summer holidays in the Mediterranean and opting for coolcations in search of destinations with milder climates. Climate adaptation is becoming a priority and, in the face of increasingly intense heatwaves, may boost the appeal of spring and early autumn.
Two Copernicus services have independently confirmed that global sea surface temperatures have broken records for this time of year. Daily data from the Copernicus Climate Change Service exceeded the 2024 levels on 21 June, reaching 20.86 °C, higher than the 20.83 °C recorded in 2023 and 2024. Data from the Copernicus Marine Watch Service show temperatures of 21.0 °C on 21 June, beating the 2023 and 2024 records by 0.1 °C. This unprecedented warming is linked to the onset of El Niño (announced by the WMO and declared by NOAA on 11 June) and to record-breaking sea surface temperatures in the North Pacific; consequences are anticipated for weather patterns, the global climate and marine ecosystems.